99 Recruiting Leukemia Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Leukemia
Related Conditions
Top Recruiting Leukemia Studies
Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia
📍 Naval Medical Center - San Diego — San Diego, California
View Study & Checklist ➔AZD6738 for Patients With Progressive MDS or CMML
📍 BIDMC — Boston, Massachusetts
View Study & Checklist ➔Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies
📍 The Children's Hospital of Philadelphia — Philadelphia, Pennsylvania
View Study & Checklist ➔Treatment of Relapsed or Chemotherapy Refractory Chronic Lymphocytic Leukemia or Indolent B Cell Lymphoma Using Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL
📍 University of Chicago — Chicago, Illinois
View Study & Checklist ➔Mindfulness Interventions to Improve Health Activation, Coping, and Stress Among Childhood Cancer Survivors
📍 St. Jude Children's Research Hospital — Memphis, Tennessee
View Study & Checklist ➔A Feasibility and Safety Study of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ Leukemia
📍 Children's Hospital Los Angeles — Los Angeles, California
View Study & Checklist ➔Talazoparib for Cohesin-Mutated AML and MDS With Excess Blasts
📍 Beth Israel Deaconess Medical Center — Boston, Massachusetts
View Study & Checklist ➔Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
📍 City of Hope Phoenix — Goodyear, Arizona
View Study & Checklist ➔Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔CD19-specific CAR T Cells With a Fully Human Binding Domain for CD19+ Leukemia or Lymphoma
📍 Children's Hospital Los Angeles — Los Angeles, California
View Study & Checklist ➔Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia
📍 Fort Wayne Medical Oncology and Hematology — Fort Wayne, Indiana
View Study & Checklist ➔PCI-32765 for Special Cases of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
📍 National Institutes of Health Clinical Center, 9000 Rockville Pike — Bethesda, Maryland
View Study & Checklist ➔A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔Nivolumab and/or Ipilimumab With or Without Azacitidine in Treating Patients With Myelodysplastic Syndrome
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Precursor B Cell Acute Lymphoblastic Leukemia (B-ALL) Treated With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔Helical Tomotherapy, Fludarabine Phosphate, and Melphalan Followed By Allo-HSCT in Hematological Malignancies
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD22 for Relapsed/Refractory Leukemia or Lymphoma
📍 Children's Hospital Los Angeles — Los Angeles, California
View Study & Checklist ➔Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔Study of Gene Modified Donor T Cell Infusion in Patients With Recurrent Disease After Allogeneic Transplant
📍 BMT Program at Northside Hospital — Atlanta, Georgia
View Study & Checklist ➔Combination of Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL-SLL)
📍 University of Texas MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Weight Gain in Pediatric Leukemia Survivors
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
📍 Children's Hospital of Philadelphia — Philadelphia, Pennsylvania
View Study & Checklist ➔Mosunetuzumab for CLL MRD Clearance
📍 Brigham & Women's Hospital — Boston, Massachusetts
View Study & Checklist ➔CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL
📍 University of Chicago Medicine Comprehensive Cancer Center — Chicago, Illinois
View Study & Checklist ➔Genomically Profiling, Collecting, Archiving and Distributing Hematologic Malignancy Specimens
📍 Connecticut Children's Medical Center — Hartford, Connecticut
View Study & Checklist ➔Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT)
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Study of Pedi-cRIB: Mini-Hyper-CVD With Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric With B-Cell Lineage Acute Lymphocytic Leukemia
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
📍 Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio
View Study & Checklist ➔A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔Exercise as an Immune Adjuvant for Allogeneic Cell Therapies
📍 The University of Arizona — Tucson, Arizona
View Study & Checklist ➔A Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia
📍 St. Jude Children's Research Hospital — Memphis, Tennessee
View Study & Checklist ➔Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia
📍 University of Colorado Hospital — Aurora, Colorado
View Study & Checklist ➔Effects of Using a Storybook, to Explain Leukemia to Children Versus the Standard Child Life Intervention, on Parental Stress.
📍 Children's Hospital Los Angeles — Los Angeles, California
View Study & Checklist ➔Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant
📍 University of Nebraska Medical Center — Omaha, Nebraska
View Study & Checklist ➔Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell Malignancies
📍 Stanford University — Palo Alto, California
View Study & Checklist ➔Strength Training Exercise in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (STEP-ALL)
📍 University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center — Chapel Hill, North Carolina
View Study & Checklist ➔Improving Communication and Building a Stronger Medical Home Among Spanish-speaking Families
📍 Children's Hospital Colorado — Aurora, Colorado
View Study & Checklist ➔Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
📍 Sylvester Comprehensive Cancer Center — Miami, Florida
View Study & Checklist ➔